Sarossa Capital Overview

  • Year Founded
  • 1988

Year Founded

  • Status
  • Private

  • Employees
  • 1

Employees

  • Latest Deal Type
  • PIPE

  • Latest Deal Amount
  • $663K

  • Investors
  • 7

Sarossa Capital General Information

Description

Sarossa PLC is an investment holding and management company. Its principal activity is an investment in and growth and development of businesses that present opportunities for value creation. It is mainly focused on portfolio businesses with product and service platforms targeting major international markets through customers and partners with an international profile. The company's equity interest in a potential investment may range from a minority position to 100 percent ownership.

Contact Information

Formerly Known As
Sarossa Plc, Sarossa Capital plc, Antisoma
Ownership Status
Privately Held (backing)
Financing Status
Corporation
Corporate Office
  • Floor 1 Liberation Station
  • The Esplanade
  • Saint Helier JE2 3AS
  • Jersey, United Kingdom
Primary Industry
Asset Management
Corporate Office
  • Floor 1 Liberation Station
  • The Esplanade
  • Saint Helier JE2 3AS
  • Jersey, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sarossa Capital Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. PIPE 08-May-2017 $663K Completed Generating Revenue
6. Secondary Transaction - Open Market Completed Generating Revenue
5. PIPE 01-May-2008 Completed Generating Revenue
4. PIPE 15-Dec-2006 Completed Generating Revenue
3. PIPE 05-Dec-2005 Completed Generating Revenue
2. PIPE 22-Feb-2002 $31.3M $31.3M Completed Generating Revenue
1. IPO 16-Dec-1999 Completed Generating Revenue
To view Sarossa Capital’s complete valuation and funding history, request access »

Sarossa Capital Patents

Sarossa Capital Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-0604114-D0 Combinations for the treatment of cancer Inactive 02-Mar-2006
GB-0519397-D0 Biological materials and uses thereof Inactive 23-Sep-2005
GB-0519398-D0 Biological materials and uses thereof Inactive 23-Sep-2005
WO-2007034210-A2 Deglycosylated anti-muc-1 antibodies and uses thereof Inactive 23-Sep-2005
WO-2007034210-A3 Deglycosylated anti-muc-1 antibodies and uses thereof Inactive 23-Sep-2005 C07K16/3092
To view Sarossa Capital’s complete patent history, request access »

Sarossa Capital Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sarossa Capital Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Blake Holdings Holding Company Minority
CDIB BioScience Venture Management Venture Capital Minority
Joe W. and Dorothy Dorsett Brown Foundation Impact Investing Minority
Minerva Ventures Corporation Minority
Still River Fund Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Sarossa Capital Acquisitions (1)

Sarossa Capital’s most recent deal was a Merger/Acquisition with Xanthus Pharmaceuticals for . The deal was made on 11-Jun-2008.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Xanthus Pharmaceuticals 11-Jun-2008 Merger/Acquisition Drug Discovery
To view Sarossa Capital’s complete acquisitions history, request access »

Sarossa Capital FAQs

  • When was Sarossa Capital founded?

    Sarossa Capital was founded in 1988.

  • Where is Sarossa Capital headquartered?

    Sarossa Capital is headquartered in Saint Helier, United Kingdom.

  • What is the size of Sarossa Capital?

    Sarossa Capital has 1 total employees.

  • What industry is Sarossa Capital in?

    Sarossa Capital’s primary industry is Asset Management.

  • Is Sarossa Capital a private or public company?

    Sarossa Capital is a Private company.

  • What is Sarossa Capital’s current revenue?

    The current revenue for Sarossa Capital is .

  • How much funding has Sarossa Capital raised over time?

    Sarossa Capital has raised $136M.

  • Who are Sarossa Capital’s investors?

    Blake Holdings, CDIB BioScience Venture Management, Joe W. and Dorothy Dorsett Brown Foundation, Minerva Ventures, and Still River Fund are 5 of 7 investors who have invested in Sarossa Capital.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process